Edition:
United Kingdom

Skyline Medical Inc (SKLN.OQ)

SKLN.OQ on NASDAQ Stock Exchange Capital Market

1.05USD
14 Dec 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.05
Open
$1.05
Day's High
$1.07
Day's Low
$1.02
Volume
10,511
Avg. Vol
45,576
52-wk High
$4.18
52-wk Low
$1.00

Latest Key Developments (Source: Significant Developments)

Skyline Medical Files For Resale Of Up To 1.9 Mln Shares By Selling Stockholder
Friday, 8 Dec 2017 

Dec 8 (Reuters) - Skyline Medical Inc ::SKYLINE MEDICAL INC FILES FOR RESALE OF UP TO 1.9 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILING.  Full Article

Skyline Medical and Helomics Announce Joint Strategic Partnership With GLG Pharma
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Helomics Corp ::SKYLINE MEDICAL AND HELOMICS ANNOUNCE A JOINT STRATEGIC PARTNERSHIP WITH GLG PHARMA.SKYLINE MEDICAL - ‍NEW PARTNERSHIP TO FILE FOR EUROPEAN GRANT APPLICATION TO EXPAND GLG'S AND SKYLINE-HELOMICS VENTURE'S PRODUCT OFFERING​ ACROSS EUROPE.  Full Article

Skyline Medical, Helomics Corp sign joint venture to commercialize D-CHIP platform
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Helomics Corp :Skyline Medical and Helomics Corporation sign joint venture term sheet to build-out and commercialize the D-CHIP platform.Skyline Medical Inc - ‍joint venture is subject to terms and conditions, including further due diligence and financing of new entity​.Skyline Medical Inc - ‍signed a term sheet with Helomics Corporation​.Skyline Medical Inc - ‍deal to leverage Helomics D-CHIP platform to develop and market new approaches for personalized cancer diagnosis and care​.Skyline Medical Inc - ‍skyline Medical will own 51 pct of joint venture, with Helomics owning remaining 49 pct​.Skyline Medical Inc - operations of JV will be managed by Helomics subject to direction and oversight of joint venture's board of directors​.  Full Article

Skyline Medical reports Q3 loss per share $0.16
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Skyline Medical Inc :Skyline Medical reports 2017 third quarter financial results.Q3 loss per share $0.16.Q3 revenue $152,500 versus $134,600.  Full Article

Skyline Medical partners with Device Technologies
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Skyline Medical Inc ::Says ‍has partnered with Device Technologies to market STREAMWAY System in Australia, New Zealand, Fiji and Pacific Islands​.  Full Article

Skyline Medical proposes two joint ventures
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Skyline Medical Inc :Two proposed joint ventures with Helomics Corporation and Cytobioscience​.Proposed jv with Cytobioscience, privately held biomedical co, will provide skyline with access to CYTOBIOSCIENCE' research services​.Merger agreement between co, Cytobioscience announced on Aug 9 terminated in order to focus on structuring proposed joint venture​.  Full Article

Skyline Medical signs distribution agreements in Canada and Switzerland
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Skyline Medical Inc ::Skyline Medical Inc expands international presence by signing distribution agreements in Canada and Switzerland.Skyline Medical - ‍ partnered with 2 independent distributors to support sales of co's streamway system to medical centers in Canada, Switzerland​.  Full Article

Skyline Medical files for offering of up to 1.93 mln common shares
Friday, 9 Dec 2016 

Skyline Medical Inc :Files for offering of up to 1.93 million shares of common stock - sec filing.  Full Article

Skyline Medical signs agreement for GLG Pharma to be exclusive distributor of Streamway System in the U.K.
Tuesday, 1 Nov 2016 

Skyline Medical Inc : Skyline Medical signs agreement for GLG Pharma to be exclusive distributor of Streamway System in the U.K. .Under terms of agreement, GLG will be responsible for all sales and marketing activities.  Full Article

Skyline Medical files for mixed shelf of upto $20 million
Friday, 23 Sep 2016 

Skyline Medical Inc ::.  Full Article

BRIEF-Skyline Medical Files For Resale Of Up To 1.9 Mln Shares By Selling Stockholder

* SKYLINE MEDICAL INC FILES FOR RESALE OF UP TO 1.9 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILING Source text: (http://bit.ly/2BQ55m2) Further company coverage:

No consensus analysis data available.